Circadian variation of isoniazid pharmacokinetics in mice

Souayed, Nouha; Chennoufi, Malek; Frej, Nadia Ben; Chaabane, Amel; Ben‐Attia, Mossadok; Aouam, Karim; Reinberg, A; Boughattas, Naceur A.

doi:10.1016/j.biopha.2016.10.054

Cited by 9 publications

(1 citation statement)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Deletion of the clock from hepatocytes reduced the expression and activity of NADPH–cytochrome P450 oxidoreductase, resulting in lower acetaminophen toxicity. Isoniazid is partly metabolized by CYP2E1‐mediated oxidation to hepatotoxic compounds (Souayed et al, 2016). Its greater toxicity at ZT 1 coincided with higher C max and AUC in plasma, as shown in chronopharmacokinetic studies (Table 2).…”

Section: Chronopharmacokinetics: Non‐clinical Datamentioning

confidence: 99%

Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics

Bicker

Alves

Falcão

2020

British J Pharmacology

View full text Add to dashboard Cite

The importance of drug dosing time in pharmacokinetics, pharmacodynamics, and toxicity is receiving increasing attention from the scientific community. In spite of mounting evidence that circadian oscillations affect drug absorption, distribution, metabolism, and excretion (ADME), there remain many unanswered questions in this field and, occasionally, conflicting experimental results. Such data arise not only from translational difficulties caused by interspecies differences but also from variability in study design and a lack of understanding of how the circadian clock affects physiological factors that strongly influence ADME, namely, the expression and activity of drug transporters. Hence, the main goal of this review is to provide an updated analysis of the role of the circadian rhythm in drug absorption, distribution across bloodtissue barriers, metabolism in hepatic and extra-hepatic tissues, and hepatobiliary and renal excretion. It is expected that the research suggestions proposed here will contribute to a tissue-targeted and time-targeted pharmacotherapy.

show abstract

Section: Chronopharmacokinetics: Non‐clinical Datamentioning

confidence: 99%